Urgent^® PC
Macroplastique^®

Urgent^® PC
Macroplastique^®

Frequently Asked Questions
Prior Authorization Request
Coverage Denials
Appeals
Keys to a Successful Appeal
Other Resources

Urgent^® PC Clinical Data

There are numerous publications highlighting the use of percutaneous tibial nerve stimulation (PTNS) in the treatment of urinary urgency, urinary frequency and urge incontinence.

The Urgent PC Neuromodulation System is the only system available to provide PTNS treatment. The device technology and treatment protocol are founded on the SANS device (Stoller’s Afferent Nerve Stimulator).

Uroplasty recently commissioned a meta-analysis of studies highlighting the use of PTNS for the treatment of urinary urgency, urinary frequency and urge incontinence. Results of the analysis indicated that the majority of patients responded to PTNS (71%). Reductions in the number of voids, void volume and voids per night were highly significant.

The following abstracts are listed by publication year with the most recent listed first.  

Click on the article title to view the full abstract:

A randomized multicenter study comparing percutaneous tibial nerve stimulation with pharmaceutical therapy for the treatment of overactive bladder.
             By Peters, K.M., et al. (2008). Presentation, Late Breaking Science Forum, American Urological Association Annual Meeting, Orlando, FL. 

Prospective randomized study for long term efficacy of percutaneous tibial nerve stimulation (PTNS) in patients with over active bladder: Maintenance protocol.
            By Farahat, Y.A. (2007). Abstract, 4th Pan Arab Continence Society Congress, Qatar.

Who are the best candidates to be treated with percutaneous tibial nerve stimulation (PTNS)?  A retrospective analysis of responder rate in different patient populations.
             By Finazzi-Agrò, E., et al. (2007). European Urology Supplement, 6(2),141.

Peripheral tibial neurostimulation (PTNS) versus tolterodine in the treatment of women with urge urinary incontinence and urge symptoms. 
            By Preyer, O., et al. (2007). Intern Urogynecol J: Suppl 1.

Percutaneous tibial nerve stimulation: The Urgent PC device. 
            By van Balkan, M.R. (2007).Expert Rev Med Devices, 4(5), 693-698.

Percutaneous tibial nerve stimulation (PTNS): Results at long-term follow-up.
            By Cappellano, F., et al. (2006). Poster, SIUD National Congress, Italy.

Posterior tibial nerve stimulation (PTNS) in the treatment of LUTS secondary to Parkinson’s Disease.
            By Finazzi-Agrò, E., et al. (2006). Poster, SUID National Congress, Italy.

Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation. 
            By van der Pal, F., et al. (2006). BJU Intl, 97(1), 113-116.

Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: Is maintenance treatment necessary?
            By van der Pal, F., et al. (2006). BJU Intl, 97(3), 547-550.

Prognostic factors for successful percutaneous tibial nerve stimulation.
            By van Balken, M.R., et al. (2006). Eur Urol, 49(2), 360-365.

Percutaneous tibial nerve stimulation (PTNS) in the treatment of urge incontinence: A double blind placebo controlled study. 
            By Finazzi-Agrò, E. et al. (2005).  Poster, SIUD National Congress, Italy.

Posterior tibial nerve stimulation (PTNS): Is the once-a-week protocol the best option? 
            By Finazzi-Agrò, E., et al. (2005). Minerva Urol Nefrol, 57(2), 119-123.

Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms.
            By Ruiz, B.C., et al. (2004). Eur Urol, 45(1), 65-69.

Posterior tibial nerve stimulation in the treatment of voiding dysfunction: Urodynamic data. 
            By Vandoninck, V., et al. (2004). Neuro Urodyn, 23, 246-251.

Percutaneous tibial nerve stimulation in the treatment of overactive bladder: Urodynamic data. 
            By Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 227-232.

Posterior tibial nerve stimulation in the treatment of urge incontinence.
            By Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 17-23.

Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder.
            By Mazo, E.B., & Krivoborodov, G.G. (2002). Zurnal Voprosy Nejrochirurgii Imeni NN Burdenko, 1, 17-21.

The efficacy of Stoller Afferent Nerve Stimulation in frequency/urgency syndrome: A randomised control trial.
            By Vohra, A.K., et al. (2002). Abstract 217, ICS 32nd Annual Meeting, Heidelberg.

Percutaneous afferent neuromodulation for the refractory overactive bladder: Results of a multicenter study.
            By Govier, F.E., et al. (2001). J Urol, 165, 1193-1198.

Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction.
            By van Balken, M.R., et al. (2001). J Urol, 166(3), 914-918.

Use of peripheral neuromodulation of the S3 region for a treatment of detrusor overactivity: A urodynamic-based study. 
            By Klingler, H.C., et al. (2000). Urol, 56, 766-771.

Afferent nerve stimulation for pelvic floor dysfunction.
            By Stoller, M.L. (1999). Eur Urol, 35 (suppl 2), 16.

0540054D 8/08